29 August 2022 - - US-based biopharmaceutical company ANI Pharmaceuticals, Inc (NASDAQ: ANIP) has launched of Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg, the company said.

ANI's Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg are the generic version of the Reference Listed Drug Compazine and were developed in technical collaboration with Biophore India Pharmaceuticals Pvt. Ltd.

The current annual US market for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg is approximately USD 30m, according to IQVIA/IMS Health, a leading healthcare data and analytics provider.

ANI Pharmaceuticals is in developing, manufacturing, and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need.

Biophore India Pharmaceuticals, an established pharmaceutical company, is engaged in the development and manufacturing of niche, high quality pharmaceutical products for the generic industry.